ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Gene Therapy for a Mucopolysaccharidosis Type I Murine Model with Lentiviral-IDUA Vector
Human Gene Therapy
◽
10.1089/hum.2005.16.81
◽
2005
◽
Vol 16
(1)
◽
pp. 81-90
◽
Cited By ~ 53
Author(s):
Carmela Di Domenico
◽
Guglielmo R.D. Villani
◽
Daniele Di Napoli
◽
Enrico Gonzalez Y Reyero
◽
Angelo Lombardo
◽
...
Keyword(s):
Gene Therapy
◽
Murine Model
◽
Type I
◽
Mucopolysaccharidosis Type
◽
Mucopolysaccharidosis Type I
Download Full-text
Related Documents
Cited By
References
69. Gene therapy of mucopolysaccharidosis type I: Intraventricular administration of adeno-associated virus vector transducing the human alpha-l-iduronidase gene in a murine model of the disease
Molecular Genetics and Metabolism
◽
10.1016/j.ymgme.2007.10.081
◽
2008
◽
Vol 93
(2)
◽
pp. 31
Author(s):
R. Scott McIvor
◽
Daniel A. Wolf
◽
Zhenhong Nan
◽
Mayra Quito
◽
Kelly Podetz-Pedersen
◽
...
Keyword(s):
Gene Therapy
◽
Murine Model
◽
Virus Vector
◽
Type I
◽
Intraventricular Administration
◽
Mucopolysaccharidosis Type
◽
Mucopolysaccharidosis Type I
◽
Adeno Associated Virus
Download Full-text
11 Adeno-associated virus vector-mediated gene therapy in a murine model of mucopolysaccharidosis type I
Molecular Genetics and Metabolism
◽
10.1016/j.ymgme.2007.08.016
◽
2007
◽
Vol 92
(4)
◽
pp. 13-14
Author(s):
Lalitha Belur
◽
Zachary deMorest
◽
Chester B. Whitley
◽
Walter C. Low
◽
R. Scott McIvor
Keyword(s):
Gene Therapy
◽
Murine Model
◽
Virus Vector
◽
Type I
◽
Mucopolysaccharidosis Type
◽
Mucopolysaccharidosis Type I
◽
Adeno Associated Virus
Download Full-text
Intranasal gene delivery of AAV9 iduronidase: A non-invasive and effective gene therapy approach for prevention of neurologic disease in a murine model of mucopolysaccharidosis type I
Molecular Genetics and Metabolism
◽
10.1016/j.ymgme.2015.12.195
◽
2016
◽
Vol 117
(2)
◽
pp. S26
Author(s):
Lalitha Belur
◽
Megan Buckvold
◽
Kelly M. Podetz-Pedersen
◽
Maureen Riedl
◽
Lucy Vulchanova
◽
...
Keyword(s):
Gene Therapy
◽
Gene Delivery
◽
Murine Model
◽
Type I
◽
Mucopolysaccharidosis Type
◽
Neurologic Disease
◽
Mucopolysaccharidosis Type I
◽
Therapy Approach
◽
Gene Therapy Approach
◽
Non Invasive
Download Full-text
Sexual behaviour in a murine model of mucopolysaccharidosis type I (MPS I)
PLoS ONE
◽
10.1371/journal.pone.0220429
◽
2019
◽
Vol 14
(12)
◽
pp. e0220429
◽
Cited By ~ 1
Author(s):
Ana Barbosa Mendes
◽
Cinthia Castro do Nascimento
◽
Vânia D’Almeida
Keyword(s):
Sexual Behaviour
◽
Murine Model
◽
Type I
◽
Mucopolysaccharidosis Type
◽
Mucopolysaccharidosis Type I
◽
Mps I
Download Full-text
Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I
Proceedings of the National Academy of Sciences
◽
10.1073/pnas.1413645111
◽
2014
◽
Vol 111
(41)
◽
pp. 14894-14899
◽
Cited By ~ 24
Author(s):
C. Hinderer
◽
P. Bell
◽
B. L. Gurda
◽
Q. Wang
◽
J.-P. Louboutin
◽
...
Keyword(s):
Gene Therapy
◽
Type I
◽
Mucopolysaccharidosis Type
◽
Mucopolysaccharidosis Type I
Download Full-text
879. Direct Administration of AAV Vectors Encoding Human α-L-Iduronidase to the CNS in a Murine Model of Mucopolysaccharidosis Type I
Molecular Therapy
◽
10.1016/s1525-0016(16)40282-0
◽
2008
◽
Vol 16
◽
pp. S328
Keyword(s):
Murine Model
◽
Type I
◽
Mucopolysaccharidosis Type
◽
Mucopolysaccharidosis Type I
◽
Direct Administration
Download Full-text
Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy
Brain Research Bulletin
◽
10.1016/j.brainresbull.2007.07.018
◽
2007
◽
Vol 74
(6)
◽
pp. 429-438
◽
Cited By ~ 24
Author(s):
Mayra F. Garcia-Rivera
◽
Leah E. Colvin-Wanshura
◽
Matthew S. Nelson
◽
Zhenhong Nan
◽
Shaukat A. Khan
◽
...
Keyword(s):
Gene Therapy
◽
Stem Cell
◽
Mouse Model
◽
Type I
◽
Mucopolysaccharidosis Type
◽
Mucopolysaccharidosis Type I
◽
Human Stem Cell
◽
Preclinical Testing
◽
Cell And Gene Therapy
Download Full-text
Investigation of the bone damage in mucopolysaccharidosis type I Hurler Syndrome: Pathophysiological mechanisms and the impact of ex vivo gene therapy
Bone Reports
◽
10.1016/j.bonr.2020.100597
◽
2020
◽
Vol 13
◽
pp. 100597
Author(s):
Sara Penna
◽
Stefania Crippa
◽
Valentina Capo
◽
Ludovica Santi
◽
Roberto Bosotti
◽
...
Keyword(s):
Gene Therapy
◽
Ex Vivo
◽
Type I
◽
Mucopolysaccharidosis Type
◽
Hurler Syndrome
◽
Mucopolysaccharidosis Type I
◽
Pathophysiological Mechanisms
◽
Bone Damage
◽
Ex Vivo Gene Therapy
◽
The Impact
Download Full-text
PEGylated cationic nanoemulsions can efficiently bind and transfect pIDUA in a mucopolysaccharidosis type I murine model
Journal of Controlled Release
◽
10.1016/j.jconrel.2015.04.013
◽
2015
◽
Vol 209
◽
pp. 37-46
◽
Cited By ~ 12
Author(s):
Michelle Fraga
◽
Fernanda Bruxel
◽
Dirnete Diel
◽
Talita Giacomet de Carvalho
◽
Carlos Alberto Perez
◽
...
Keyword(s):
Murine Model
◽
Type I
◽
Mucopolysaccharidosis Type
◽
Mucopolysaccharidosis Type I
Download Full-text
88. Lentiviral vector optimization for IDUA expression in the murine model of Hurler syndrome (mucopolysaccharidosis type I)
Molecular Genetics and Metabolism
◽
10.1016/j.ymgme.2007.10.100
◽
2008
◽
Vol 93
(2)
◽
pp. 36-37
Author(s):
Paul Score
◽
Arthur T. Johnson
◽
Chester B. Whitley
Keyword(s):
Vector Optimization
◽
Murine Model
◽
Lentiviral Vector
◽
Type I
◽
Mucopolysaccharidosis Type
◽
Hurler Syndrome
◽
Mucopolysaccharidosis Type I
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close